ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc (KPTI)

0,566534
-0,03187
( -5,33% )
Mis à jour : 17:41:06

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
0,566534
Prix Achat
0,5665
Prix Vente
0,5678
Volume échangé
1 265 092
0,5074 Fourchette du Jour 0,605
0,5074 Plage de 52 semaines 1,70
Cap du marché
Clôture Veille
0,5984
Ouverture
0,54
Dernière Transaction
1
@
0.5673
Dernière heure de transaction
17:41:36
Volume financier
US$ 721 821
VWAP
0,570568
Volume moyen (3 m)
1 012 056
Actions en circulation
125 314 506
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,51
Bénéfice par action (BPA)
-1,14
Chiffre d'affairess
146,03M
Bénéfice net
-143,1M

À propos de Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharm's lead com... Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of first-in-class drugs directed against nuclear export for the treatment of cancer and other diseases. Karyopharm's lead compound, XPOVIO(R) (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade(R) (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Karyopharm Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker KPTI. Le dernier cours de clôture d'Karyopharm Therapeutics était de US$0,60. Au cours de la dernière année, les actions de Karyopharm Therapeutics ont été négociées dans une fourchette de prix de US$ 0,5074 à US$ 1,70.

Karyopharm Therapeutics compte actuellement 125 314 506 actions en circulation. La capitalisation boursière d'Karyopharm Therapeutics est de US$74,99 million. Karyopharm Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.51.

KPTI Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.063466-10.0739682540.630.65210.507412154770.60685648CS
4-0.123466-17.89362318840.690.71690.50748531830.62419699CS
12-0.273466-32.55547619050.840.860.507410120560.68557976CS
26-0.268466-32.15161676650.8351.130.50748522240.76366837CS
52-0.673466-54.31177419351.241.70.50749963240.97049731CS
156-9.433466-94.334661010.990.507418573333.21591089CS
260-15.073466-96.377659846515.6429.610.507419193517.37343426CS

KPTI - Frequently Asked Questions (FAQ)

What is the current Karyopharm Therapeutics share price?
The current share price of Karyopharm Therapeutics is US$ 0,566534
How many Karyopharm Therapeutics shares are in issue?
Karyopharm Therapeutics has 125 314 506 shares in issue
What is the market cap of Karyopharm Therapeutics?
The market capitalisation of Karyopharm Therapeutics is USD 74,99M
What is the 1 year trading range for Karyopharm Therapeutics share price?
Karyopharm Therapeutics has traded in the range of US$ 0,5074 to US$ 1,70 during the past year
What is the PE ratio of Karyopharm Therapeutics?
The price to earnings ratio of Karyopharm Therapeutics is -0,51
What is the cash to sales ratio of Karyopharm Therapeutics?
The cash to sales ratio of Karyopharm Therapeutics is 0,5
What is the reporting currency for Karyopharm Therapeutics?
Karyopharm Therapeutics reports financial results in USD
What is the latest annual turnover for Karyopharm Therapeutics?
The latest annual turnover of Karyopharm Therapeutics is USD 146,03M
What is the latest annual profit for Karyopharm Therapeutics?
The latest annual profit of Karyopharm Therapeutics is USD -143,1M
What is the registered address of Karyopharm Therapeutics?
The registered address for Karyopharm Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Karyopharm Therapeutics website address?
The website address for Karyopharm Therapeutics is www.karyopharm.com
Which industry sector does Karyopharm Therapeutics operate in?
Karyopharm Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VRMVroom Inc
US$ 25,50
(410,00%)
2,21k
STECSantech Holdings Limited
US$ 2,18
(235,23%)
94,29M
PEPGPepGen Inc
US$ 3,09
(125,55%)
82,87M
RETOReTo Eco Solutions Inc
US$ 0,7983
(96,67%)
62,19M
YYAIConnexa Sports Technologies Inc
US$ 1,22
(90,60%)
107,93M
THTarget Hospitality Corporation
US$ 4,03
(-56,94%)
6,42M
NKLANikola Corporation
US$ 0,262899
(-30,82%)
32,41M
WIMIWiMi Hologram Cloud Inc
US$ 0,9074
(-28,55%)
15M
WDCWestern Digital Corporation
US$ 49,19
(-28,40%)
5,43M
STAIScanTech AI Systems Inc
US$ 2,3602
(-28,26%)
3,04M
NVDANVIDIA Corporation
US$ 134,135
(-0,22%)
116,38M
YYAIConnexa Sports Technologies Inc
US$ 1,22
(90,60%)
109,9M
CNEYCN Energy Group Inc
US$ 0,258
(5,48%)
106,54M
PLTRPalantir Technologies Inc
US$ 93,05
(-8,19%)
105,68M
STECSantech Holdings Limited
US$ 2,18
(235,23%)
95,08M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock